Search Results

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...

This fact sheet is intended for people who have latent TB infection. The resource provides general information on latent TB infection and emphasizes the importance of taking medicine to treat latent TB infection. 

The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.

The purpose of this manual is to provide the clinician with updated recommendations for managing the drug-drug interactions that occur when using antiretroviral therapy during tuberculosis treatment.

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the Northeastern National Tuberculosis Center. This booklet provides information on treatment for TB infection, treatment for TB disease, and how to stay...

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the New Jersey Medical School Global Tuberculosis Institute. All of these patient education materials can be found on the following webpage: www.cdc.gov/tb...

This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at...

This pocket guide is intended to assist clinicians in managing patients with HIV and  LTBI, and drug-susceptible pulmonary TB disease. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.